What stands out most is the gap between what we *measure* and what actually *matters*. When people who look “healthy” by conventional standards are still developing early cardiovascular disease, that’s not an individual failure—it’s a systems failure. Risk models built on incomplete or non-representative data will inevitably miss entire populations, and South Asians are a clear example of that blind spot.
The point about fat distribution is especially critical. Visceral and hepatic fat don’t announce themselves the way subcutaneous fat does, yet they are far more metabolically active and dangerous. If clinicians (and patients) are relying heavily on BMI or even basic lipid panels, they’re often seeing a reassuring picture that isn’t telling the full story.
It also reinforces something that doesn’t get enough attention in preventive care: *early and tailored screening matters*. For South Asians, that likely means looking beyond standard panels—things like insulin resistance markers, triglyceride-to-HDL ratio, liver fat indicators, and earlier glucose monitoring. Not because this population is “unhealthy,” but because the baseline risk profile is different.
I also appreciate how you broadened the frame beyond one group. The larger issue is that medicine has historically treated “average” as universal, when in reality it’s often just “most studied.” As more diverse longitudinal data emerges (like from the MASALA study), it should push a shift toward more personalized, population-aware prevention strategies.
If anything, posts like this highlight a key takeaway:
we need to move from reactive care based on late signals to proactive care based on *true risk*, even when it’s not immediately visible.
Curious how you think this should translate at the primary care level—what would you want to see change first: screening guidelines, physician education, or patient awareness?
I think patient and physician awareness is paramount. First, a patient needs to be able to advocate for themselves during their health checkups, but for those patients who can’t, the physician needs to be able to fill the gap. Minority and marginalized populations are understudied, and it’s imperative as physicians to not only be aware of guidelines but to understand that those guidelines may miss the individual patient in front of them. An individualized approach to patient care is crucial, not only for racial and ethnic minorities, but for historically marginalized groups that don’t get enrolled into clinical trials.
This is an important and overdue callout.
What stands out most is the gap between what we *measure* and what actually *matters*. When people who look “healthy” by conventional standards are still developing early cardiovascular disease, that’s not an individual failure—it’s a systems failure. Risk models built on incomplete or non-representative data will inevitably miss entire populations, and South Asians are a clear example of that blind spot.
The point about fat distribution is especially critical. Visceral and hepatic fat don’t announce themselves the way subcutaneous fat does, yet they are far more metabolically active and dangerous. If clinicians (and patients) are relying heavily on BMI or even basic lipid panels, they’re often seeing a reassuring picture that isn’t telling the full story.
It also reinforces something that doesn’t get enough attention in preventive care: *early and tailored screening matters*. For South Asians, that likely means looking beyond standard panels—things like insulin resistance markers, triglyceride-to-HDL ratio, liver fat indicators, and earlier glucose monitoring. Not because this population is “unhealthy,” but because the baseline risk profile is different.
I also appreciate how you broadened the frame beyond one group. The larger issue is that medicine has historically treated “average” as universal, when in reality it’s often just “most studied.” As more diverse longitudinal data emerges (like from the MASALA study), it should push a shift toward more personalized, population-aware prevention strategies.
If anything, posts like this highlight a key takeaway:
we need to move from reactive care based on late signals to proactive care based on *true risk*, even when it’s not immediately visible.
Curious how you think this should translate at the primary care level—what would you want to see change first: screening guidelines, physician education, or patient awareness?
I think patient and physician awareness is paramount. First, a patient needs to be able to advocate for themselves during their health checkups, but for those patients who can’t, the physician needs to be able to fill the gap. Minority and marginalized populations are understudied, and it’s imperative as physicians to not only be aware of guidelines but to understand that those guidelines may miss the individual patient in front of them. An individualized approach to patient care is crucial, not only for racial and ethnic minorities, but for historically marginalized groups that don’t get enrolled into clinical trials.